Company intelligence / Profile preview

C&B Capital

Seoul, South Korea

Ownership: Private
Development stage: Other

Overview

C&B Capital is a South Korean venture capital firm that specializes in early-stage investments within the biotechnology, healthcare, and information and communications technology (ICT) sectors. Founded in 2017, the firm provides growth capital and strategic support to innovative startups, particularly those developing novel therapeutics, medical devices, and digital health solutions. C&B Capital is known for its active role in the Korean biotech ecosystem, partnering with academic institutions and research centers to identify high-potential spin-offs. The firm's portfolio includes several prominent Korean biotech companies, reflecting its focus on advancing medical innovation through targeted financial investment.

Industry: Investors

Beyond the preview

Go deeper on C&B Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on C&B Capital.

Explore the full profile